Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Convergent Ca2+ and Zn2+ signaling regulates apoptotic Kv2.1 K+ currents.

Proceedings of the National Academy of Sciences of the United States of America | 2013

A simultaneous increase in cytosolic Zn(2+) and Ca(2+) accompanies the initiation of neuronal cell death signaling cascades. However, the molecular convergence points of cellular processes activated by these cations are poorly understood. Here, we show that Ca(2+)-dependent activation of Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) is required for a cell death-enabling process previously shown to also depend on Zn(2+). We have reported that oxidant-induced intraneuronal Zn(2+) liberation triggers a syntaxin-dependent incorporation of Kv2.1 voltage-gated potassium channels into the plasma membrane. This channel insertion can be detected as a marked enhancement of delayed rectifier K(+) currents in voltage clamp measurements observed at least 3 h following a short exposure to an apoptogenic stimulus. This current increase is the process responsible for the cytoplasmic loss of K(+) that enables protease and nuclease activation during apoptosis. In the present study, we demonstrate that an oxidative stimulus also promotes intracellular Ca(2+) release and activation of CaMKII, which, in turn, modulates the ability of syntaxin to interact with Kv2.1. Pharmacological or molecular inhibition of CaMKII prevents the K(+) current enhancement observed following oxidative injury and, importantly, significantly increases neuronal viability. These findings reveal a previously unrecognized cooperative convergence of Ca(2+)- and Zn(2+)-mediated injurious signaling pathways, providing a potentially unique target for therapeutic intervention in neurodegenerative conditions associated with oxidative stress.

Pubmed ID: 23918396 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

None found

Associated grants

  • Agency: NINDS NIH HHS, United States
    Id: R01 NS043277
  • Agency: NINDS NIH HHS, United States
    Id: R21 NS078238
  • Agency: NINDS NIH HHS, United States
    Id: NS043277
  • Agency: NHLBI NIH HHS, United States
    Id: HL080632
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL080632
  • Agency: NINDS NIH HHS, United States
    Id: R56 NS043277

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Anti-Kv2.1 K+ Channel Antibody (antibody)

RRID:AB_10672253

This monoclonal targets Kv2.1 potassium channel

View all literature mentions

Anti-Kv2.1 K+ Channel Antibody (antibody)

RRID:AB_10673392

This monoclonal targets Kv2.1 K+ channel

View all literature mentions